NTBLQ

NOTABLE LABS LTD by Notable Labs, Ltd. (NTBLQ)

About NOTABLE LABS LTD by Notable Labs, Ltd. (NTBLQ)

Notable Labs Ltd. is a clinical-stage platform therapeutics company that develops predictive medicines for patients with cancer. Through its proprietary Predictive Medicines Platform, the firm predicts whether or not that patient is likely to respond to that specific therapeutic. The company's Predictive Medicines Platform is designed to identify and select patients expected to be clinically responsive prior to their treatment to improve patient outcomes and fast-track clinical development. The firm's product candidate, Volasertib, is a Polo-like Kinase 1 inhibitor. Notable Labs was founded on January 31, 2000 and is headquartered in Foster City, CA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.22
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
8
P/E ratio
.00

NOTABLE LABS LTD by Notable Labs, Ltd. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.22
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
8
P/E ratio
.00